Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Another series of anti-HIV chemokine CCR5 antagonists presented by Takeda

Oct. 4, 2004

New anticytomegalovirus agents prepared and tested at Bayer

Oct. 4, 2004

Novel antiinflammatory chalcones patented by Taiwan university researchers

Oct. 4, 2004

Pyrazole-based antiplatelet agents newly developed at Daiichi

Oct. 1, 2004

New beta-lactamase-resistant carbapenems discovered at Sankyo

Oct. 1, 2004

New vanilloid VR1 antagonists and their use in pain, urinary incontinence, etc.

Oct. 1, 2004

Novel MCH antagonists in early development at Aventis

Oct. 1, 2004

Novel glycogen phosphorylase inhibitors developed by Aventis team

Oct. 1, 2004

Abbott presents new PDE4 and TNF-alpha production inhibitors

Oct. 1, 2004

New leucomycin A7 derivatives and their use in Gram-positive bacterial infections

Oct. 1, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...